You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 61 No. 2, February 1950 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (11)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

TREATMENT OF SYPHILIS WITH AUREOMYCIN ADMINISTERED BY MOUTH

ROBERT R. KIERLAND, M.D.; WALLACE E. HERRELL, M.D.; PAUL A. O'LEARY, M.D.

Arch Derm Syphilol. 1950;61(2):185-195.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

WHAT MIGHT be called the "antibiotic era" of syphilotherapy began with the introduction of penicillin in the treatment of syphilis. Naturally, therefore, antibiotics developed since the introduction of penicillin also have been examined for their possible value in the treatment of syphilis. The new antibiotic aureomycin appears to have a wide range of antibacterial activity. The present report is concerned with an expansion of our previously reported investigations on its oral use in the treatment of syphilis.

It was evident from the report by Heilman1 that aureomycin possesses antispirochetal activity which is greater than that of penicillin against experimental infectious relapsing fever and leptospirosis icterohaemorrhagica. His observations led us to administer aureomycin orally to patients with early infectious syphilis2 and to patients with late cutaneous syphilis and neurosyphilis3. The results obtained showed that aureomycin has definite antisyphilitic activity when administered by . . . [Full Text PDF of this Article]


Author Affiliations

ROCHESTER, MINN.

From the Section on Dermatology and Syphilology (Dr. Kierland and Dr. O'Leary) and the Division of Medicine (Dr. Herrell), Mayo Clinic.


Footnotes

Supplies of aureomycin were provided by Lederle Laboratories Division, American Cyanamid Company.

Read at the Sixty-Ninth Annual Meeting of the American Dermatological Association, Inc., Hot Springs, Va., May 27, 1949.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1950 American Medical Association. All Rights Reserved.